NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. NeoTract is a very high achieving organization that operates under a set of standards that promote innovation, collaboration and integrity at all times. Customer focused, NeoTract employs a sales force of urology consultants, who strive to partner with our customers to improve their practices by offering access to superior state of the art healthcare.
The company’s initial focus is the UroLift ® System treatment for men suffering from enlarged prostate (benign prostatic hyperplasia, BPH). This minimally invasive permanent implant system is clinically proven to be one of the only BPH treatment options to rapidly and effectively treat urinary symptoms while preserving normal sexual function. UroLift is now available throughout the USA, Europe, Australia, Canada, Mexico and South Korea.
NeoTract, Inc. was founded in 2004 through the ExploraMed Development, LLC medical device incubator funded by New Enterprise Associates. ExploraMed has launched several medical device companies that are based on innovative solutions to important clinical needs. NeoTract headquarters are in Pleasanton, California, USA.